• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    United Kingdom Stocks, ETFs To Watch After Keir Starmer, Labour Party Win

    7/5/24 12:53:39 PM ET
    $AZN
    $BP
    $DEO
    $GSK
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Integrated oil Companies
    Energy
    Get the next $AZN alert in real time by email

    Labour Party member Keir Starmer is set to become the new prime minister of the United Kingdom with a win over the Rishi Sunak-led Conservative Party.

    The win marks an end to 14 years of Conservative Party control in the United Kingdom. The Labour Party will also have one of the largest majority government leads in the country in 25 years, as reported by CNN.

    "A mandate like this comes with a great responsibility," Starmer said Friday.

    Starmer promised to put "country first, party second" in his victory speech.

    UK Stocks & ETFS: Gains for United Kingdom stocks and ETFs were minimal on Friday with the results of the election potentially priced in and others dissecting what the Labour Party in control means for certain sectors.

    The iShares MSCI United Kingdom ETF (NYSE:EWU) is up 0.5% on Friday. The largest U.K. ETF has $2.8 billion in assets under management and holds 80 stocks representing the largest companies in the country.

    The top holdings are:

    AstraZeneca PLC (NASDAQ:AZN)

    Shell PLC (NYSE:SHEL)

    HSBC Holdings (NYSE:HSBC)

    Unilever PLC (NYSE:UL)

    BP PLC (NYSE:BP)

    RELX PLC (NYSE:RELX)

    GlaxoSmithKline PLC (NYSE:GSK)

    Rio Tinto PLC (NYSE:RIO)

    Diageo PLC (NYSE:DEO)

    Glencore PLC (OTC:GLNCY)

    Eight of the 10 largest holdings are up Friday at the time of writing, with HSBC and Rio Tinto trading lower.

    The top weightings in the iShares ETF are the categories of financials (19.3%), consumer staples (16.4%) and energy (13.4%).

    The Franklin FTSE United Kingdom ETF (NYSE:FLGB) also offers exposure to the country with 107 holdings. The fund has all the same top 10 holdings as the iShares MSCI United Kingdom ETF, in a slightly different order and at smaller weightings. The ETF's largest categories are financials (19.5%), consumer staples (15.5%) and energy (14.4%).

    Another ETF option is the iShares MSCI United Kingdom Small Cap ETF (BATS:EWUS). The ETF holds 231 stocks and has smaller weightings for the small-cap components it holds. The top categories for the ETF are industrials (21.5%), financials (19.8%) and consumer discretionary (14.8%).

    What Experts Are Saying: British private bank and wealth management company Coutts sees policy changes from the Labour Party leadership taking time to materialize.

    "In terms of what this means for the U.K. population and our clients, we will closely monitor the developments of a Keir Starmer government and its potential impact on markets," Coutts Chief Investment Officer Fahad Kamal said.

    Kamal said history shows U.K. elections don't tend to have a "long-term impact on markets."

    The CIO said it could be "business as usual" for the United Kingdom. One item to closely monitor is falling inflation in the country and the potential for rate cuts soon, which could improve economic growth in the country, he said.

    RBC Capital analysts see the homebuilding sector in the United Kingdom benefitting with a Labour Party win, as reported by CNBC. The analysts said the new leadership and policy pledges could lead to a "new age" for homebuilding in the country.

    "Over the last few years housebuilders' potential has been hamstrung, but over the next few this potential is likely to be unleashed," the RBC analysts said.

    It is worth noting the iShares MSCI United Kingdom Small Cap ETF counts the real estate sector as its fourth-largest weighting at 12.3%, which could make the ETF stand out based on policy. The EWU and FLGB ETFs have 0.8% and 1.1% exposure to the real estate sector, respectively.

    Allianz also sees opportunity in U.K. homebuilders with the Labour Party win and likely cuts to interest rates ahead.

    "We expect rules and regulations around planning permissions to be quickly relaxed by the incoming government," Allianz said.

    Allianz also sees opportunity in U.K.-listed mining companies thanks to the electrification of the energy supply.

    Citi has a preference for the FTSE 250 over the FTSE 100, preferring small to mid-cap sized companies over large caps, as reported by Investing.com.

    "We see an improving balance of risks for UK SMID caps, which have underperformed, but are expected to have superior growth vs. large caps. SMID caps are also better positioned to benefit from rate cuts and a pick-up in dealmaking," Citi said.

    Sectors like real estate and utilities were mentioned positively by Citi in the post-election comments.

    Related Link:

    • British Pound, European Stocks Surge Ahead Of UK Election Results; Bitcoin Plummets: What’s Driving Markets Thursday?

    Photo via Shutterstock.

    Get the next $AZN alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $AZN
    $BP
    $DEO
    $GSK

    CompanyDatePrice TargetRatingAnalyst
    BP p.l.c.
    $BP
    5/19/2025$29.00Buy → Hold
    Jefferies
    BP p.l.c.
    $BP
    5/12/2025$26.50Equal-Weight → Underweight
    Morgan Stanley
    AstraZeneca PLC
    $AZN
    4/15/2025$75.00Outperform
    Exane BNP Paribas
    GSK plc
    $GSK
    4/15/2025$35.25Neutral
    Exane BNP Paribas
    BP p.l.c.
    $BP
    4/10/2025Buy → Neutral
    UBS
    Rio Tinto Plc
    $RIO
    4/9/2025Overweight → Equal-Weight
    Morgan Stanley
    Diageo plc
    $DEO
    4/2/2025Buy
    Berenberg
    RELX PLC PLC
    $RELX
    3/26/2025Buy
    Goldman
    More analyst ratings

    $AZN
    $BP
    $DEO
    $GSK
    Leadership Updates

    Live Leadership Updates

    See more
    • GSK and Lifetime® launch original movie to raise awareness about the impact of meningitis

      Pretty Hurts, a new Lifetime Original Movie brought to you by GSK, informs Lifetime's mom audience about meningococcal disease, known as meningitis Partnership is part of GSK's Ask2BSure campaign, which encourages parents of teens and young adults ages 16-23 to start a conversation with their teen's doctor about meningitis and vaccination Hollywood moms of teens, Alyson Hannigan and Sarah Michelle Gellar, team up with GSK and Ask2BSure to help raise awareness GSK plc (LSE/NYSE:GSK) today announced its sponsorship of Pretty Hurts, a gripping new Lifetime Original Movie and the latest extension of GSK's Ask2BSure public health campaign. Premiering on June 28, 2025, at 8 p.m. ET/7 p.m.

      5/9/25 9:00:00 AM ET
      $GSK
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • NOTICE OF 2025 ANNUAL GENERAL MEETING

      NOTICE OF 2025 ANNUAL GENERAL MEETING Shell plc's 2025 Annual General Meeting ("AGM") scheduled to be a hybrid meeting, facilitating both physical and virtual attendance Shareholders encouraged to vote in advance of the AGM, but voting enabled during the meeting for those formally in attendance Today, Shell plc (the "Company") posted its Notice of 2025 Annual General Meeting (the "Notice"), which can be viewed and downloaded from shell.com/agm. The AGM is scheduled to be held at the Sofitel London Heathrow Hotel – Terminal 5, London Heathrow Airport, London TW6 2GD at 10:00 (UK time) on Tuesday May 20, 2025. Further details on how to join or watch the AGM can be found within the Notice.

      4/16/25 9:36:17 AM ET
      $SHEL
      Oil & Gas Production
      Energy
    • LexisNexis Risk Solutions Names Valentina Isakina as Chief Strategy Officer

      ATLANTA, April 8, 2025 /PRNewswire/ -- LexisNexis® Risk Solutions has announced the appointment of Valentina Isakina as its Executive Vice President and Chief Strategy Officer, reporting to Mark Kelsey, Chief Executive Officer. In this critical leadership role, Isakina will oversee the strategic direction and corporate development initiatives for LexisNexis Risk Solutions and drive continued growth and innovation across the company's global operations. Working with the executive leadership team at LexisNexis Risk Solutions, Isakina will play a pivotal role in helping to shape

      4/8/25 8:30:00 AM ET
      $RELX
      Business Services
      Consumer Discretionary

    $AZN
    $BP
    $DEO
    $GSK
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Nucala (mepolizumab) approved by US FDA for use in adults with chronic obstructive pulmonary disease (COPD)

      Nucala is the only approved biologic studied in a wide COPD population with an eosinophilic phenotype characterized by blood eosinophil count (BEC) starting at 150 cells/μL Approval based on the positive MATINEE and METREX phase III trials MATINEE data included reduction of exacerbations leading to hospitalization and/or emergency department visits Nearly 70% of patients in the US who are inadequately controlled on inhaled triple therapy have a BEC ≥150 cells/μL GSK plc (LSE/NYSE:GSK) today announced that the US Food and Drug Administration (FDA) has approved Nucala (mepolizumab) as an add-on maintenance treatment for adult patients with inadequately controlled COPD and an eosinoph

      5/22/25 4:15:00 PM ET
      $GSK
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • LexisNexis Risk Solutions Launches New ADAM Program Interactive Dashboard to Help Recover Missing Children

      New Tool Empowers the Public to Search Geo-Targeted Alerts on Missing Children – Released in Honor of National Missing Children's Day and the Program's 25th Anniversary ATLANTA, May 22, 2025 /PRNewswire/ -- LexisNexis® Risk Solutions has announced the launch of a powerful new Interactive Dashboard designed to aid in the recovery of missing children. This innovative, AI-driven tool allows the public to easily search geo-targeted alerts sent through the ADAM Program (Automated Delivery of Alerts on Missing Children) and view missing child posters by location, and other filters.

      5/22/25 10:00:00 AM ET
      $RELX
      Business Services
      Consumer Discretionary
    • USBG PRESENTS WORLD CLASS SPONSORED BY DIAGEO CROWNED NIC WALLACE AS THE 2025 U.S. BARTENDER OF THE YEAR

      The nation's Top 30 bartenders participated in a series of challenges to send one champion to the Global Finals in Toronto NEW YORK, May 21, 2025 /PRNewswire/ -- The thirteenth season of the United States Bartenders' Guild (USBG) Presents World Class Sponsored By Diageo has named Nic Wallace as the 2025 U.S. Bartender of the Year. Hosted in Atlanta, GA, Nic Wallce of Darien, GA was crowned as the winner after a three-day, five-part challenge competition showcasing the best in class cocktail craftsmanship. The acclaimed competition brought the country's Top 30 Competitors to test their bartending skills, agility and creativity.  Nic Wallace impressed judges with his attention to detail and cr

      5/21/25 1:37:00 PM ET
      $DEO
      Beverages (Production/Distribution)
      Consumer Staples

    $AZN
    $BP
    $DEO
    $GSK
    Financials

    Live finance-specific insights

    See more
    • SHELL PLC – REPORT ON PAYMENTS TO GOVERNMENTS FOR THE YEAR 2024

      Shell plc – Report on Payments to Governments for the year 2024 Basis for preparation – Report on Payments to Governments for the year 2024This Report provides a consolidated overview of the payments to governments made by Shell plc and its subsidiary undertakings (hereinafter referred to as "Shell") for the year 2024 as required under the UK's Reports on Payments to Governments Regulations 2014 (as amended in December 2015). These UK Regulations enact domestic rules in line with Directive 2013/34/EU (the EU Accounting Directive (2013)) and apply to large UK incorporated companies like Shell that are involved in the exploration, prospection, discovery, development and extraction of minerals

      5/15/25 5:53:27 AM ET
      $SHEL
      Oil & Gas Production
      Energy
    • Publication of Prospectus

      Shell International Finance B.V. and Shell plc 12 May 2025 Publication of Prospectus The following prospectus has been approved by the UK Financial Conduct Authority and is available for viewing: Information Memorandum dated 9 May 2025 relating to the Multi-Currency Debt Securities Programme of Shell International Finance B.V. (as Issuer) and Shell plc (as Issuer and as Guarantor) The Information Memorandum constitutes a base prospectus for the purposes of Regulation (EU) 2017/1129 as it forms part of United Kingdom domestic law by virtue of the European Union (Withdrawal) Act 2018. Full information on Shell International Finance B.V. and Shell plc is only available on the basis of t

      5/12/25 2:59:35 AM ET
      $SHEL
      Oil & Gas Production
      Energy
    • Shell announces commencement of a share buyback programme

      Shell plc   Shell announces commencement of a share buyback programme May 2, 2025 Shell plc (the ‘Company') today announces the commencement of a $3.5 billion share buyback programme covering an aggregate contract term of approximately three months (the ‘programme'). The purpose of the programme is to reduce the issued share capital of the Company. All shares repurchased as part of the programme will be cancelled. It is intended that, subject to market conditions, the programme will be completed prior to the Company's Q2 2025 results announcement, scheduled for July 31, 2025. The Company has entered into an arrangement with a single broker consisting of two irrevocable, non-discretionary

      5/2/25 2:03:00 AM ET
      $SHEL
      Oil & Gas Production
      Energy

    $AZN
    $BP
    $DEO
    $GSK
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4: GLAXOSMITHKLINE PLC converted options into 700,772 units of Common Stock and bought $4,950,000 worth of Common Stock (275,000 units at $18.00)

      4 - GLAXOSMITHKLINE PLC (0001131399) (Reporting)

      7/6/21 4:38:14 PM ET
      $GSK
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form 3 filed by GLAXOSMITHKLINE PLC

      3 - GLAXOSMITHKLINE PLC (0001131399) (Reporting)

      7/6/21 4:22:59 PM ET
      $GSK
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form 4: GLAXOSMITHKLINE PLC converted options into 30,253,189 units of Common Stock

      4 - GLAXOSMITHKLINE PLC (0001131399) (Reporting)

      6/23/21 6:14:59 PM ET
      $GSK
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $AZN
    $BP
    $DEO
    $GSK
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by GSK plc

      SC 13G/A - GSK plc (0001131399) (Subject)

      11/12/24 4:32:59 PM ET
      $GSK
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Amendment: SEC Form SC 13G/A filed by HSBC Holdings plc.

      SC 13G/A - HSBC HOLDINGS PLC (0001089113) (Filed by)

      9/3/24 5:38:30 PM ET
      $HSBC
      Savings Institutions
      Finance
    • SEC Form SC 13G/A filed by GSK plc (Amendment)

      SC 13G/A - GSK plc (0001131399) (Subject)

      2/13/24 1:37:25 PM ET
      $GSK
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $AZN
    $BP
    $DEO
    $GSK
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • BP downgraded by Jefferies with a new price target

      Jefferies downgraded BP from Buy to Hold and set a new price target of $29.00

      5/19/25 8:48:32 AM ET
      $BP
      Integrated oil Companies
      Energy
    • BP downgraded by Morgan Stanley with a new price target

      Morgan Stanley downgraded BP from Equal-Weight to Underweight and set a new price target of $26.50

      5/12/25 8:21:07 AM ET
      $BP
      Integrated oil Companies
      Energy
    • Exane BNP Paribas initiated coverage on AstraZeneca with a new price target

      Exane BNP Paribas initiated coverage of AstraZeneca with a rating of Outperform and set a new price target of $75.00

      4/15/25 12:40:56 PM ET
      $AZN
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $AZN
    $BP
    $DEO
    $GSK
    SEC Filings

    See more
    • SEC Form 6-K filed by HSBC Holdings plc.

      6-K - HSBC HOLDINGS PLC (0001089113) (Filer)

      5/23/25 1:03:05 PM ET
      $HSBC
      Savings Institutions
      Finance
    • SEC Form 6-K filed by GSK plc

      6-K - GSK plc (0001131399) (Filer)

      5/23/25 12:50:27 PM ET
      $GSK
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form 6-K filed by AstraZeneca PLC

      6-K - ASTRAZENECA PLC (0000901832) (Filer)

      5/23/25 8:56:02 AM ET
      $AZN
      Biotechnology: Pharmaceutical Preparations
      Health Care